Skip to main content

Table 1 Baseline characeteristics of study patients

From: A randomized, placebo-controlled trial to determine the course of aminotransferase elevation during prolonged acetaminophen administration

 

Placebo (n = 47)

Acetaminophen (n = 205)

Age (years)

32 (19.0, 64.0)

34 (18.0 to 74.0)

Male

12 (25.5%)

57 (27.8%)

Race

  

White

35 (74.5%)

142 (69.3%)

 Hispanic

4 (8.5%)

33 (16.1%)

 Black

4 (8.5%)

13 (6.3%)

 Other/Mixed

4 (8.5%)

17 (8.3%)

Body Mass Index

23.8 (17.3, 48.8)

25.8 (16.5, 53.5)

Self-reported ethanol use

35 (74.5%)

167 (81.5%)

Baseline ALT

17.0 (11.0, 47.0)

19.0(9.0, 44.0)

  1. Note: median (range) were provided for Age, BMI and Baseline ALT.